Editorial
Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
-
Correspondence: Margaret A Shupnik mas3x@virginia.edu
Department of Medicine, University of Virginia Medical School, Jefferson Park Avenue, Charlottesville, Virginia 22903, USA
Breast Cancer Research 2007, 9:107 doi:10.1186/bcr1735
Published: 29 June 2007Abstract
In the previous issue of the journal, Lin and coworkers present data demonstrate that increased expression of estrogen receptor (ER)-β in ER-α-positive breast cancer cells antagonizes a defined group of ER-α/estrogen stimulated genes that are involved in cell cycle regulation and DNA replication. Similar expression patterns for these genes were found human ER-α positive breast tumors expressing higher levels or ER-β, and this correlated with better clinical outcome. The implications for these data, which suggest that ER-β is a positive actor and diagnostic marker for therapeutic outcome, are discussed.